Cargando…

Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors

Mimickers of neuroendocrine neoplasms (NEN) include a number of important pitfall tumors. Here, we describe our experience with mesenchymal mimics of NENs to illustrate their spectrum and draw the attention particularly to a group of mesenchymal/non-epithelial neoplasms (MN) that combine epithelioid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasajima, Atsuko, Konukiewitz, Björn, Schlitter, Anna Melissa, Weichert, Wilko, Bräsen, Jan Hinrich, Agaimy, Abbas, Klöppel, Günter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724147/
https://www.ncbi.nlm.nih.gov/pubmed/34350470
http://dx.doi.org/10.1007/s00428-021-03156-9
_version_ 1784625864016658432
author Kasajima, Atsuko
Konukiewitz, Björn
Schlitter, Anna Melissa
Weichert, Wilko
Bräsen, Jan Hinrich
Agaimy, Abbas
Klöppel, Günter
author_facet Kasajima, Atsuko
Konukiewitz, Björn
Schlitter, Anna Melissa
Weichert, Wilko
Bräsen, Jan Hinrich
Agaimy, Abbas
Klöppel, Günter
author_sort Kasajima, Atsuko
collection PubMed
description Mimickers of neuroendocrine neoplasms (NEN) include a number of important pitfall tumors. Here, we describe our experience with mesenchymal mimics of NENs to illustrate their spectrum and draw the attention particularly to a group of mesenchymal/non-epithelial neoplasms (MN) that combine epithelioid histology with neuroendocrine (NE-) features and peculiar genetic abnormalities. In a consultation series of 4498 cases collected between 2009 and 2021, 2099 neoplasms expressing synaptophysin and/or chromograninA were reviewed and analyzed. A total of 364 (18%) were diagnosed as non-NENs, while the remaining tumors were NEN. The group of mesenchymal/non-epithelial neoplasms with NE-features (MN-NE) included 31/364 (8%) cases. These mostly malignant neoplasms showed an epithelioid morphology. While all but one tumor expressed synaptophysin, mostly patchy, only 10/29 (34%) co-expressed chromograninA. A total of 13/31 (42%) of the MN-NE showed EWSR1-related gene fusions (6 Ewing sarcomas, 5 clear cell sarcomas, and 1 desmoplastic small round cell tumor, 1 neoplasm with FUS-CREM gene fusion) and 7 (23%) were SWI/SNF (SMARCB1 or SMARCA4)-deficient neoplasms. The remaining MN-NE included synovial sarcoma, sclerosing epithelioid mesenchymal neoplasm, melanoma, alveolar soft part sarcoma, solitary fibrous tumor, and chordoma. A total of 27/31 MN-NE were from the last 8 years, and 6 of them were located in the pancreas. Eleven MN-NE were initially diagnosed as neuroendocrine carcinomas (NECs). MN-NE with epithelioid features play an increasing role as mimickers of NECs. They mostly belong to tumors with gene fusions involving the EWSR1 gene, or with SWI/SNF complex deficiency. Synaptophysin expression is mostly patchy and chromograninA expression is infrequent in MN-NE of this series and data extracted from literature. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00428-021-03156-9.
format Online
Article
Text
id pubmed-8724147
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-87241472022-01-13 Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors Kasajima, Atsuko Konukiewitz, Björn Schlitter, Anna Melissa Weichert, Wilko Bräsen, Jan Hinrich Agaimy, Abbas Klöppel, Günter Virchows Arch Original Article Mimickers of neuroendocrine neoplasms (NEN) include a number of important pitfall tumors. Here, we describe our experience with mesenchymal mimics of NENs to illustrate their spectrum and draw the attention particularly to a group of mesenchymal/non-epithelial neoplasms (MN) that combine epithelioid histology with neuroendocrine (NE-) features and peculiar genetic abnormalities. In a consultation series of 4498 cases collected between 2009 and 2021, 2099 neoplasms expressing synaptophysin and/or chromograninA were reviewed and analyzed. A total of 364 (18%) were diagnosed as non-NENs, while the remaining tumors were NEN. The group of mesenchymal/non-epithelial neoplasms with NE-features (MN-NE) included 31/364 (8%) cases. These mostly malignant neoplasms showed an epithelioid morphology. While all but one tumor expressed synaptophysin, mostly patchy, only 10/29 (34%) co-expressed chromograninA. A total of 13/31 (42%) of the MN-NE showed EWSR1-related gene fusions (6 Ewing sarcomas, 5 clear cell sarcomas, and 1 desmoplastic small round cell tumor, 1 neoplasm with FUS-CREM gene fusion) and 7 (23%) were SWI/SNF (SMARCB1 or SMARCA4)-deficient neoplasms. The remaining MN-NE included synovial sarcoma, sclerosing epithelioid mesenchymal neoplasm, melanoma, alveolar soft part sarcoma, solitary fibrous tumor, and chordoma. A total of 27/31 MN-NE were from the last 8 years, and 6 of them were located in the pancreas. Eleven MN-NE were initially diagnosed as neuroendocrine carcinomas (NECs). MN-NE with epithelioid features play an increasing role as mimickers of NECs. They mostly belong to tumors with gene fusions involving the EWSR1 gene, or with SWI/SNF complex deficiency. Synaptophysin expression is mostly patchy and chromograninA expression is infrequent in MN-NE of this series and data extracted from literature. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00428-021-03156-9. Springer Berlin Heidelberg 2021-08-05 2021 /pmc/articles/PMC8724147/ /pubmed/34350470 http://dx.doi.org/10.1007/s00428-021-03156-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Kasajima, Atsuko
Konukiewitz, Björn
Schlitter, Anna Melissa
Weichert, Wilko
Bräsen, Jan Hinrich
Agaimy, Abbas
Klöppel, Günter
Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors
title Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors
title_full Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors
title_fullStr Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors
title_full_unstemmed Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors
title_short Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors
title_sort mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and swi/snf-deficient tumors
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724147/
https://www.ncbi.nlm.nih.gov/pubmed/34350470
http://dx.doi.org/10.1007/s00428-021-03156-9
work_keys_str_mv AT kasajimaatsuko mesenchymalnonepithelialmimickersofneuroendocrineneoplasmswithafocusonfusiongeneassociatedandswisnfdeficienttumors
AT konukiewitzbjorn mesenchymalnonepithelialmimickersofneuroendocrineneoplasmswithafocusonfusiongeneassociatedandswisnfdeficienttumors
AT schlitterannamelissa mesenchymalnonepithelialmimickersofneuroendocrineneoplasmswithafocusonfusiongeneassociatedandswisnfdeficienttumors
AT weichertwilko mesenchymalnonepithelialmimickersofneuroendocrineneoplasmswithafocusonfusiongeneassociatedandswisnfdeficienttumors
AT brasenjanhinrich mesenchymalnonepithelialmimickersofneuroendocrineneoplasmswithafocusonfusiongeneassociatedandswisnfdeficienttumors
AT agaimyabbas mesenchymalnonepithelialmimickersofneuroendocrineneoplasmswithafocusonfusiongeneassociatedandswisnfdeficienttumors
AT kloppelgunter mesenchymalnonepithelialmimickersofneuroendocrineneoplasmswithafocusonfusiongeneassociatedandswisnfdeficienttumors